Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…
West Virginia House Approves Medical Cannabis Edibles Bill
West Virginia medical cannabis program expands to include edible formulations, offering patients improved access and treatment options. Edibles provide pharmacokinetic advantages for those with respiratory issues or needing longer symptom relief. This…
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
The CBD endometriosis trial backed by the NHS is entering its dosing phase, offering hope for better pain management. This trial focuses on cannabidiol's role in treating chronic pelvic pain associated with endometriosis. Access to clinical trial data…
High Tide Joins U.S. National Compassionate Care Council | HITI Stock News
Compassionate care frameworks are critical pathways for patients needing medical cannabis for serious conditions. These frameworks support improved access and consistent product standards. Efforts to reform medical cannabis policy focus on evidence-based…
A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care
Digital therapeutics cannabinoid medicine offers new tools for precise symptom tracking and treatment adjustment in medical cannabis care. This framework supports individualized dosing and accountable therapeutic protocols. It helps close evidence gaps…
What a Major Study Reveals About Cannabis Use and Brain Aging
Cannabis use and brain aging is a complex relationship explored in a major study using large biobank datasets. The research suggests initial differences in brain age metrics among cannabis users but no straightforward harmful or protective effects. This…
Comparing Psychiatric Outcomes in Cannabis Use Disorder and Other Substance Disorders
This article examines psychiatric outcomes cannabis use disorder comparison with other substance use disorders. Understanding these differences aids clinicians in screening and counseling patients effectively. The focus on real-world data highlights the…
Endocannabinoid System Research: Cannabis & Autism Risk
Peripregnancy cannabis exposure autism risks have been linked to behavioral and developmental differences in children. Research shows varying effects depending on autism spectrum disorder symptoms. This highlights concerns about cannabis use from…
Endocannabinoid System & Maternal Cytokines: Clinical Research
Maternal immune suppression cannabis use during pregnancy is linked to changes in key cytokines. This clinical research highlights the biological effects on maternal immune function. Understanding these effects is critical for counseling pregnant…
Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk
Clinical trials reveal that cannabis-induced psychosis risk is significant for developing schizophrenia spectrum and bipolar disorders. This risk underscores the importance of long-term psychiatric follow-up. Early monitoring after cannabis-induced…
